Keaven M Anderson

Keaven M Anderson

Merck & Co, Inc.
Verified email at merck.com
Cited by 47724
Clinical trials group sequential design survival analysis multiplicity
Jason Clark

Jason Clark

Biometrics Team Leader, AstraZeneca
Verified email at astrazeneca.com
Cited by 3955
Clinical Trials Biometrics Biostatistics Group Sequential Design
Qi An

Qi An

Biostatistics, University of Florida
Verified email at ufl.edu
Cited by 167
Group sequential design Survival analysis Clinical trial
Budhaditya Goswami

Budhaditya Goswami

Sr. Manager Biostatistics, Pfizer, Chennai
Verified email at pfizer.com
Cited by 145
Multiple Testing Group Sequential Design Meta analysis Bayesian Statistics Machine Learning
Subhayan Mondal

Subhayan Mondal

Statistician, Johnson and Johnson
Verified email at its.jnj.com
Cited by 134
Survival Analysis Group Sequential Design
Pranab Ghosh

Pranab Ghosh

Pfizer Inc.
Verified email at pfizer.com
Cited by 124
Biostatistics Clinical trial Group sequential design multi arm trials adaptive design
Hao Sun

Hao Sun

Biostatistician, Bristol Myers Squibb
Verified email at bms.com
Cited by 15
Clinical Trial Design Dose Finding Dose Optimization Dynamic Borrowing Group Sequential Design